Artal Group S.A. - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 57 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2020$3,317,000
-48.3%
285,000
-28.8%
0.08%
-54.7%
Q2 2020$6,412,000
+114.1%
400,000
-20.0%
0.18%
+40.9%
Q1 2020$2,995,000
-54.6%
500,0000.0%0.13%
-50.2%
Q4 2019$6,600,000
+6.3%
500,0000.0%0.26%
+2.4%
Q3 2019$6,210,000
-22.9%
500,0000.0%0.25%
-23.6%
Q2 2019$8,050,000
-43.2%
500,000
+11.1%
0.33%
-43.6%
Q1 2019$14,162,000
-9.2%
450,000
-5.3%
0.58%0.0%
Q4 2018$15,599,000
+1.7%
475,000
-5.0%
0.58%
+44.9%
Q3 2018$15,335,000
+9.0%
500,000
-4.8%
0.40%
+33.4%
Q2 2018$14,065,000525,0000.30%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2019
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders